Published: 2024-02-19 Author: Danny Sullivan | Published on: February 19, 2024 | Last updated: February 19, 2024 Longevity biotech company Rejuvenate Bio has revealed a strategic partnership to advance the development and commercialization of its gene therapy designed to address canine osteoarthritis. The collaboration with an unnamed “global animal health company” aims to combat the...Read More